Skip to content
Men Under Microscope – Lifestyle
Author:
ViaNautis
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
September 9, 2026
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
May 7, 2026